東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Breast cancer = from bench to person...

Shakil Malik, Saima.

FindBook

Google Book

Amazon

博客來

Breast cancer = from bench to personalized medicine /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Breast cancer/ edited by Saima Shakil Malik, Nosheen Masood.
其他題名:	from bench to personalized medicine /
其他作者:	Shakil Malik, Saima.
出版者:	Singapore :Springer Nature Singapore : : 2022.,
面頁冊數:	xvii, 536 p. :ill., digital ;24 cm.
內容註:	Module 1_Overview of Breast Cancer -- Module 2_Cell and Molecular Biology of Breast Cancer-Diagnosis and Prognosis -- Module 3_Breast Cancer Treatment.
Contained By:	Springer Nature eBook
標題:	Breast - Cancer. -
電子資源:	https://doi.org/10.1007/978-981-19-0197-3
ISBN:	9789811901973

Breast cancer = from bench to personalized medicine /
Breast cancerfrom bench to personalized medicine /[electronic resource] :edited by Saima Shakil Malik, Nosheen Masood. - Singapore :Springer Nature Singapore :2022. - xvii, 536 p. :ill., digital ;24 cm.

Module 1_Overview of Breast Cancer -- Module 2_Cell and Molecular Biology of Breast Cancer-Diagnosis and Prognosis -- Module 3_Breast Cancer Treatment.

This book provides detailed information on the etiology, pathogenesis, diagnosis, prognosis, and treatment strategies for breast cancer. The first section of the book presents epidemiology, risk factors, histopathological, immunohistochemistry, and molecular subtypes of breast cancer based on the receptor status. It also discusses the association of breast cancer with other hormone-sensitive cancers. The second section of the book covers cover BRCA1 and BRCA2-associated breast carcinogenesis, early-stage progression of breast cancer, and noninvasive biomarkers for the early detection of breast cancer. It also discusses the role of epigenetic modifications and non-coding RNAs in breast cancer metastasis and explores these as the biomarkers and therapeutic targets for breast cancer therapy. Further, it discusses the role of fibrinolytic mechanisms and circulating tumor cells in breast cancer diagnosis, prognosis, and treatment. The book also provides an update on oral poly(ADP-ribose) polymerase (PARP) inhibitors to treat breast cancer. Finally, it offers potential new options for personalized therapies for breast cancer patients, including optimizing drug dosage and identifying genetic changes associated with cancer symptom occurrence and severity.

ISBN: 9789811901973

Standard No.: 10.1007/978-981-19-0197-3doiSubjects--Topical Terms:

561433
Breast
--Cancer.

LC Class. No.: RC280.B8

Dewey Class. No.: 616.9449

Breast cancer = from bench to personalized medicine /
LDR:02428nmm a2200325 a 4500 001 2299679
003 DE-He213
005 20220514091817.0
006 m d
007 cr nn 008maaau
008 230324s2022 si s 0 eng d
020 $a 9789811901973 $q (electronic bk.)
020 $a 9789811901966 $q (paper)
024 7 $a 10.1007/978-981-19-0197-3 $2 doi
035 $a 978-981-19-0197-3
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.B8
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.9449 $2 23
090 $a RC280.B8 $b B828 2022
245 0 0 $a Breast cancer $h [electronic resource] : $b from bench to personalized medicine / $c edited by Saima Shakil Malik, Nosheen Masood.
260 $a Singapore : $b Springer Nature Singapore : $b Imprint: Springer, $c 2022.
300 $a xvii, 536 p. : $b ill., digital ; $c 24 cm.
505 0 $a Module 1_Overview of Breast Cancer -- Module 2_Cell and Molecular Biology of Breast Cancer-Diagnosis and Prognosis -- Module 3_Breast Cancer Treatment.
520 $a This book provides detailed information on the etiology, pathogenesis, diagnosis, prognosis, and treatment strategies for breast cancer. The first section of the book presents epidemiology, risk factors, histopathological, immunohistochemistry, and molecular subtypes of breast cancer based on the receptor status. It also discusses the association of breast cancer with other hormone-sensitive cancers. The second section of the book covers cover BRCA1 and BRCA2-associated breast carcinogenesis, early-stage progression of breast cancer, and noninvasive biomarkers for the early detection of breast cancer. It also discusses the role of epigenetic modifications and non-coding RNAs in breast cancer metastasis and explores these as the biomarkers and therapeutic targets for breast cancer therapy. Further, it discusses the role of fibrinolytic mechanisms and circulating tumor cells in breast cancer diagnosis, prognosis, and treatment. The book also provides an update on oral poly(ADP-ribose) polymerase (PARP) inhibitors to treat breast cancer. Finally, it offers potential new options for personalized therapies for breast cancer patients, including optimizing drug dosage and identifying genetic changes associated with cancer symptom occurrence and severity.
650 0 $a Breast $x Cancer. $3 561433
650 0 $a Breast $x Cancer $x Molecular aspects. $3 2160346
650 0 $a Breast $x Cancer $x Treatment. $3 792963
650 1 4 $a Cancer Biology. $3 3594253
650 2 4 $a Cancer Epidemiology. $3 3594129
650 2 4 $a Cancer Genetics and Genomics. $3 3591654
700 1 $a Shakil Malik, Saima. $3 3449411
700 1 $a Masood, Nosheen. $3 3449410
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-19-0197-3
950 $a Biomedical and Life Sciences (SpringerNature-11642)